Pre-Clinical StudiesResearch
US Army’s Institute
of Surgical Research
Finds WoundStat™
Top Hemostatic Agent
Download TraumaCure
Abstract Study
Wound Stat™, please call
1-877-896-8637
The patent-pending technology behind WoundStat™ is the result of more than three years of research, and its effectiveness has been proven by an impressive array of recent scientific testing.
The technology behind the product originated at Virginia Commonwealth University's Reanimation Engineering Shock Center (VCURES). Along with conducting research on life-saving technologies, health care personnel at VCURES train more than half of the U.S. military's Special Forces medics.
WoundStat™ has been tested extensively in animal trauma models followed by the U.S. Army and the U.S. Navy/Marine Corps. Using these models, considered by some as the "gold standards" for testing ballistic wound treatments, Virginia Commonwealth University found that an early version of WoundStat™ enabled animal survival in 100 percent of testing cases, while products currently used by the military failed. That study has been published in the August 2007 issue of the Journal of Trauma. (www.jtrauma.com; Ward, K. et al)
Not only did testing show that WoundStat™ was able to stop severe arterial bleeding within three minutes, but it remained effective for at least three hours without additional manual pressure application.
Identical results emerged from testing conducted by one of the nation's premier independent medical device labs, NAMSA, in Norwood, Ohio. An observational study of the product has been done by the U.S. Army Institute for Surgical Research, which will also complete full testing soon. TraumaCure is working with the U.S. Navy and the Marine Corps as they complete their own testing of the product.
TraumaCure is continuing research for discovery and development of additional products based on the core compounds used in WoundStat™. The focus will be on ballistic injury care, surgical applications, chronic wound care, and burn care.